ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 169 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $679,000 | +3133.3% | 107,104 | +2871.8% | 0.00% | – |
| Q3 2015 | $21,000 | -53.3% | 3,604 | -33.3% | 0.00% | – |
| Q2 2015 | $45,000 | +200.0% | 5,406 | +200.0% | 0.00% | – |
| Q1 2015 | $15,000 | +25.0% | 1,802 | 0.0% | 0.00% | – |
| Q4 2014 | $12,000 | +20.0% | 1,802 | 0.0% | 0.00% | – |
| Q3 2014 | $10,000 | +42.9% | 1,802 | +76.3% | 0.00% | – |
| Q1 2014 | $7,000 | -99.0% | 1,022 | -97.4% | 0.00% | -100.0% |
| Q3 2013 | $736,000 | +11.5% | 40,004 | +6.1% | 0.00% | 0.0% |
| Q2 2013 | $660,000 | – | 37,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,000,000 | $96,720,000 | 33.30% |
| Opaleye Management Inc. | 1,670,000 | $13,460,000 | 9.94% |
| Slate Path Capital LP | 6,620,000 | $53,357,000 | 4.04% |
| Granite Point Capital Management, L.P. | 648,000 | $5,223,000 | 3.74% |
| Palo Alto Investors LP | 6,917,248 | $55,754,000 | 2.30% |
| Camber Capital Management LP | 3,000,000 | $24,180,000 | 1.90% |
| Geduld E E | 277,600 | $2,237,000 | 1.21% |
| Elk Creek Partners, LLC | 290,886 | $2,345,000 | 1.01% |
| SELZ CAPITAL LLC | 400,000 | $3,224,000 | 0.81% |
| GENERAL AMERICAN INVESTORS CO INC | 1,200,000 | $9,672,000 | 0.81% |